Longitudinal development and clinical predictors of financial toxicity among radiation oncology patients: final results of the SOCOFIN study.

Differences in the COST scores between tumor groups were explored with Kruskal–Wallis tests (Table 7 ) and yielded highly significant differences at all timepoints, with the highest significance at the 3‐month follow-up ( p = 0.009).

also in 132,142 other papers